标题
Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on Lumipulse
作者
关键词
-
出版物
Annals of Clinical and Translational Neurology
Volume 6, Issue 9, Pages 1815-1824
出版商
Wiley
发表日期
2019-08-29
DOI
10.1002/acn3.50873
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging
- (2018) Suzanne E. Schindler et al. Alzheimers & Dementia
- The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review
- (2018) Oskar Hansson et al. Alzheimers & Dementia
- CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts
- (2018) Oskar Hansson et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- A 2-Step Cerebrospinal Algorithm for the Selection of Frontotemporal Lobar Degeneration Subtypes
- (2018) Alberto Lleó et al. JAMA Neurology
- Relationship Between β-Secretase, Inflammation and Core Cerebrospinal Fluid Biomarkers for Alzheimer's Disease
- (2018) Daniel Alcolea et al. JOURNAL OF ALZHEIMERS DISEASE
- Impact of CSF storage volume on the analysis of Alzheimer's disease biomarkers on an automated platform
- (2018) Constance Delaby et al. CLINICA CHIMICA ACTA
- Cerebrospinal Fluid Aβ42/Aβ40 as a Means to Limiting Tube- and Storage-Dependent Pre-Analytical Variability in Clinical Setting
- (2017) Christelle Gervaise-Henry et al. JOURNAL OF ALZHEIMERS DISEASE
- The Cerebrospinal Fluid Aβ1–42/Aβ1–40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer’s Disease in a Clinical Setting
- (2017) Ellis Niemantsverdriet et al. JOURNAL OF ALZHEIMERS DISEASE
- CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration
- (2017) Daniel Alcolea et al. NEUROLOGY
- Concordance Between Different Amyloid Immunoassays and Visual Amyloid Positron Emission Tomographic Assessment
- (2017) Shorena Janelidze et al. JAMA Neurology
- Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer’s Disease
- (2016) Piotr Lewczuk et al. JOURNAL OF ALZHEIMERS DISEASE
- Reference measurement procedure for CSF amyloid beta (Aβ)1-42and the CSF Aβ1-42/Aβ1-40ratio - a cross-validation study against amyloid PET
- (2016) Josef Pannee et al. JOURNAL OF NEUROCHEMISTRY
- CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease
- (2016) Shorena Janelidze et al. Annals of Clinical and Translational Neurology
- The effect of beta-amyloid on face processing in young and old adults: A multivariate analysis of the BOLD signal
- (2015) Jenny R. Rieck et al. HUMAN BRAIN MAPPING
- Relationship between cortical thickness and cerebrospinal fluid YKL-40 in predementia stages of Alzheimer's disease
- (2015) Daniel Alcolea et al. NEUROBIOLOGY OF AGING
- Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study
- (2015) Julien Dumurgier et al. Alzheimers Research & Therapy
- Amyloid deposition, hypometabolism, and longitudinal cognitive decline
- (2012) Susan M. Landau et al. ANNALS OF NEUROLOGY
- Determining cut-points for Alzheimer’s disease biomarkers: statistical issues, methods and challenges
- (2012) Jonathan W Bartlett et al. Biomarkers in Medicine
- Decreased cerebrospinal fluid Aβ42correlates with brain atrophy in cognitively normal elderly
- (2009) Anne M. Fagan et al. ANNALS OF NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More